Sheaff Brock Investment Advisors LLC Has $6.17 Million Stock Holdings in The Cigna Group (NYSE:CI)

Sheaff Brock Investment Advisors LLC reduced its position in shares of The Cigna Group (NYSE:CI) by 0.3% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 22,331 shares of the health services provider’s stock after selling 63 shares during the quarter. Sheaff Brock Investment Advisors LLC’s holdings in The Cigna Group were worth $6,166,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also added to or reduced their stakes in CI. Prospera Private Wealth LLC bought a new position in shares of The Cigna Group in the 3rd quarter worth $37,000. Collier Financial acquired a new position in The Cigna Group during the fourth quarter worth $32,000. ORG Wealth Partners LLC bought a new position in shares of The Cigna Group in the fourth quarter valued at $34,000. Harbor Capital Advisors Inc. bought a new position in shares of The Cigna Group in the third quarter valued at $45,000. Finally, Compagnie Lombard Odier SCmA acquired a new position in shares of The Cigna Group during the fourth quarter valued at about $37,000. Institutional investors own 86.99% of the company’s stock.

Analyst Upgrades and Downgrades

CI has been the topic of several recent research reports. Truist Financial dropped their price target on shares of The Cigna Group from $390.00 to $375.00 and set a “buy” rating on the stock in a research report on Tuesday, February 4th. Sanford C. Bernstein lowered The Cigna Group from an “outperform” rating to a “market perform” rating and set a $323.00 target price on the stock. in a report on Thursday, February 6th. Oppenheimer decreased their price target on The Cigna Group from $400.00 to $375.00 and set an “outperform” rating for the company in a report on Friday, January 31st. Barclays dropped their price objective on The Cigna Group from $420.00 to $339.00 and set an “overweight” rating on the stock in a research note on Friday, January 31st. Finally, Deutsche Bank Aktiengesellschaft reduced their target price on shares of The Cigna Group from $398.00 to $394.00 and set a “buy” rating for the company in a research note on Monday, November 4th. Three research analysts have rated the stock with a hold rating, thirteen have issued a buy rating and two have assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $373.69.

The Cigna Group Trading Down 2.6 %

Shares of CI stock opened at $292.12 on Friday. The company has a quick ratio of 0.72, a current ratio of 0.66 and a debt-to-equity ratio of 0.70. The firm has a market cap of $81.25 billion, a P/E ratio of 23.87, a PEG ratio of 0.94 and a beta of 0.54. The company has a 50 day moving average of $286.46 and a 200-day moving average of $321.09. The Cigna Group has a 12-month low of $262.03 and a 12-month high of $370.83.

The Cigna Group (NYSE:CI) last released its earnings results on Thursday, January 30th. The health services provider reported $6.64 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $7.84 by ($1.20). The Cigna Group had a return on equity of 18.61% and a net margin of 1.39%. During the same period in the previous year, the company earned $6.79 earnings per share. Sell-side analysts anticipate that The Cigna Group will post 29.8 earnings per share for the current year.

The Cigna Group Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, March 20th. Shareholders of record on Wednesday, March 5th will be issued a dividend of $1.51 per share. The ex-dividend date of this dividend is Wednesday, March 5th. This is an increase from The Cigna Group’s previous quarterly dividend of $1.40. This represents a $6.04 annualized dividend and a yield of 2.07%. The Cigna Group’s dividend payout ratio is 45.75%.

The Cigna Group Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.